N-([1,1'-biphenyl]-4-yl)-2,2-dichloro-N-((R)-2-oxo-2-(((S)-1-phenylethyl)amino)-1-(pyridin-3-yl)ethyl)acetamide

ID: ALA5173559

Chembl Id: CHEMBL5173559

PubChem CID: 162396343

Max Phase: Preclinical

Molecular Formula: C29H25Cl2N3O2

Molecular Weight: 518.44

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)[C@@H](c1cccnc1)N(C(=O)C(Cl)Cl)c1ccc(-c2ccccc2)cc1)c1ccccc1

Standard InChI:  InChI=1S/C29H25Cl2N3O2/c1-20(21-9-4-2-5-10-21)33-28(35)26(24-13-8-18-32-19-24)34(29(36)27(30)31)25-16-14-23(15-17-25)22-11-6-3-7-12-22/h2-20,26-27H,1H3,(H,33,35)/t20-,26+/m0/s1

Standard InChI Key:  LEOCNIZCHQOMFL-RXFWQSSRSA-N

Alternative Forms

  1. Parent:

    ALA5173559

    ---

Associated Targets(Human)

PRSS1 Tclin Trypsin (2137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CASP3 Tchem Caspase-3 (3632 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPN2 Tchem Calpain1/2 (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero C1008 (1716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.44Molecular Weight (Monoisotopic): 517.1324AlogP: 6.50#Rotatable Bonds: 8
Polar Surface Area: 62.30Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.76CX Basic pKa: 4.73CX LogP: 5.76CX LogD: 5.76
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -1.05

References

1. Gai C, Harnor SJ, Zhang S, Cano C, Zhuang C, Zhao Q..  (2022)  Advanced approaches of developing targeted covalent drugs.,  13  (12.0): [PMID:36561076] [10.1039/d2md00216g]
2. Gao S, Song L, Claff T, Woodson M, Sylvester K, Jing L, Weiße RH, Cheng Y, Sträter N, Schäkel L, Gütschow M, Ye B, Yang M, Zhang T, Kang D, Toth K, Tavis J, Tollefson AE, Müller CE, Zhan P, Liu X..  (2022)  Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors.,  65  (24.0): [PMID:36475694] [10.1021/acs.jmedchem.2c01716]
3. Chen R, Gao Y, Liu H, Li H, Chen W, Ma J..  (2023)  Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020.,  14  (1): [PMID:36760740] [10.1039/d2md00344a]

Source